Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Sell
9,004
-74
-0.8% -$8.54K 0.36% 41
2025
Q4
$956K Sell
9,078
-38
-0.4% -$3.57K 0.32% 48
2025
Q3
$765K Sell
9,116
-37
-0.4% -$3.05K 0.27% 60
2025
Q2
$725K Buy
9,153
+707
+8% +$56.2K 0.27% 59
2025
Q1
$758K Buy
8,446
+342
+4% +$31.9K 0.3% 54
2024
Q4
$806K Buy
8,104
+36
+0.4% +$3.71K 0.33% 52
2024
Q3
$916K Sell
8,068
-670
-8% -$79.6K 0.36% 47
2024
Q2
$1.08M Sell
8,738
-66
-0.7% -$8.5K 0.44% 42
2024
Q1
$1.16M Buy
8,804
+662
+8% +$81.6K 0.48% 39
2023
Q4
$888K Buy
8,142
+3,730
+85% +$387K 0.39% 46
2023
Q3
$454K Buy
+4,412
New +$476K 0.22% 61

Other funds holding MRK

Rogco LP's MRK Position: Q1 2026 in Review

Rogco LP reduced its Merck (MRK) stake by 0.82% in Q1 2026, selling an estimated $8.54K and leaving 9,004 shares worth $1.08M. The position accounts for 0.36% of the portfolio, ranked #41.

Rogco LP first reported a position in MRK in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.16M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Rogco LP held 9,004 shares of Merck worth $1.08M as of Q1 2026.
  • Rogco LP sold 74 Merck shares in Q1 2026, an estimated $8.54K.
  • Merck made up 0.36% of Rogco LP's portfolio in Q1 2026, its #41 holding.
  • Rogco LP first reported a position in Merck in Q3 2023 and has held it in 11 quarters since.
  • Rogco LP's Merck position peaked at $1.16M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Rogco LP's 13F filing for Q1 2026, filed 5 May 2026.